<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Arginine vasopressin (AVP) may play a role in the development of ischemic <z:hpo ids='HP_0002181'>brain edema</z:hpo> and/or <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Data available on AVP plasma levels in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> are few and discordant </plain></SENT>
<SENT sid="2" pm="."><plain>In order to ascertain whether changes in AVP plasma levels occur in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, plasma AVP levels, plasma osmolality and mean arterial pressure were determined in 24 patients with unprecedented <z:e sem="disease" ids="C1262005" disease_type="Disease or Syndrome" abbrv="">ischemic cerebral infarction</z:e> and in 15 controls over a 24-hour period </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, mean 24-hour plasma AVP levels (7.2 +/- 0.8 ng/l) were higher (p &lt; 0.05) than in control subjects (2.4 +/- 0.3 ng/l), and correlated with the severity score of the neurologic deficit and the mean size of the lesion </plain></SENT>
<SENT sid="4" pm="."><plain>In patients with a more severe neurologic deficit, the mean 24-hour plasma AVP levels (8.7 +/- 1.0 ng/l) were higher than in patients with a less severe neurologic deficit (5.2 +/- 0.8 ng/l) </plain></SENT>
<SENT sid="5" pm="."><plain>Data indicate that in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> an increased AVP secretion occurs independently of osmotic or baroreceptorial mechanisms </plain></SENT>
<SENT sid="6" pm="."><plain>The possibility that AVP may play a role in neuronal cell damage following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> warrants further attention </plain></SENT>
</text></document>